Comments

VivoSim Labs Stock Price, Quotes and Forecasts

Q: What sector and industry does VivoSim Labs (VIVS) operate in?

VivoSim Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VIVSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.71

-0.02-1.16%

At close: -

$1.65

-0.06-3.51%

After Hours: 6:56 PM EDT

VivoSim Labs (VIVS) Forecast

News Earnings VivoSim Labs (VIVS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

VivoSim Labs Stock Price, Quotes and Forecasts | NASDAQ:VIVS | Benzinga

Explore VivoSim Labs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIVS.

Open	$1.76
Close	$1.71
Volume / Avg.	124.12K / 1.50M
Day Range	$1.66 - $1.78
52 Wk Range	1.65 - 2.28
Market Cap	$2.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.76
Close	$1.71
Volume / Avg.	124.12K / 1.50M
Day Range	$1.66 - $1.78
52 Wk Range	1.65 - 2.28
Market Cap	$2.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

About VivoSim Labs Inc.

Sector

Health Care

Industry

Biotechnology

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FX...

Got Questions? Ask

Compare VIVS performance to the market?

What is VIVS's 7 days volume trend?

What is VIVS's all-time low price?

What is VIVS's current ratio?

What is VIVS's gross margin?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy VivoSim Labs (VIVS) stock?

You can purchase shares of VivoSim Labs (NASDAQ:VIVS) through any online brokerage.

View our list of the best stock brokerages

Who are VivoSim Labs (VIVS) competitors?

Other companies in VivoSim Labs’s space includes: Galecto (NASDAQ:GLTO), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX) and Palisade Bio (NASDAQ:PALI).

What is the forecast, or price target, for VivoSim Labs (VIVS) stock?

There is no analysis for VivoSim Labs to provide a consensus price target.

What is the current price for VivoSim Labs (VIVS)?

The stock price for VivoSim Labs (NASDAQ: VIVS) is $1.65 last updated April 29, 2025 at 6:56 PM EDT.

Does VivoSim Labs (VIVS) pay a dividend?

There are no upcoming dividends for VivoSim Labs.

When is VivoSim Labs (NASDAQ:VIVS) reporting earnings?

VivoSim Labs’s Q4 earnings are confirmed for Friday, May 30, 2025.

Is VivoSim Labs (VIVS) going to split?

There is no upcoming split for VivoSim Labs.

What sector and industry does VivoSim Labs (VIVS) operate in?

VivoSim Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.